Vasopressin-2 Receptor Blockers - Mechanism of Action and Clinical Utility

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Playback speed

10 seconds

Vasopressin-2 Receptor Blockers - Mechanism of Action and Clinical Utility

By 35th Vicenza Course on AKI and CRRT FEATURING Qi Qian

384 views

June 29, 2018

0 Comments

Contrast Nephropathy

58:35

University of Colorado Department of Medicine

Updates in Nephrology

Feat. A. Jovanovich

14:51

San Diego Cardiovascular Interventions (SDCI) 2019

Avoiding Contrast Induced Nephropathy

Feat. P. Meraj

29:18

SC Liver Research Consortium

The Effective Management of Ascites and Hepatorenal Syndrome (HRS)

Feat. A. Muir

35:41

ISPAD - International Society for Pediatric and Adolescent Diabetes

Pediatric DKA New ISPAD Guidelines: Evidence and Updates

Feat. N. Glaser

22:16

Michigan Medicine

AASLD Update: Complications of Portal Hypertension

Feat. N. Ray Mazumder

13:32

Sandeep Pathak

PCNL

70:57

17th Annual Mid-Atlantic Hospital Medicine Symposium

Oncologic Hospital Emergencies: The Old and New Era

Feat. S. Pintova

24:04

UCLA Health

New Concepts in Acute Kidney Injury for the Practicing Gastroenterol…

Feat. S. Saab

47:02

John Kellum

Acute Kidney Injury and AKI Biomarkers in the ICU

18:05

AKI & CRRT Conference

What's New in ARDS?

34:34

Scripps Health

Renal Dysfunction in the Cirrhotic Patient

Feat. P. Martin

21:40

35th Vicenza Course on AKI and CRRT

Fluid Management in AKI

Feat. R. Mehta

30:47

KDIGO

KDIGO Update of AKI Guideline

Feat. M. Ostermann

28:24

35th Vicenza Course on AKI and CRRT

Fluids or no Fluids; Assessing Volume Responsiveness in the Critical…

Feat. K. Kalantari

25:00

Matthew Kaptein

Hepatorenal Syndrome: Pathophysiology and Treatment

26:02

The Texas Heart Institute

Using Augmented Intelligence as a Co-pilot in the Operating Room

Feat. Z. Khalpey

31:29

Albert Einstein College of Medicine

Hepatorenal Syndrome

Feat. A. J. Sanyal

23:01

Cedars Sinai

Acute Kidney Injury in Patients with Cirrhosis

Feat. A. Kuo

12:32

Complex Coronary Cases

Prevention of Contrast-Induced Nephropathy

Feat. S. Wender

Login

Login

Join VuMedi

Vasopressin-2 Receptor Blockers - Mechanism of Action and Clinical Utility

Related Content